Literature DB >> 28848869

Back to the Future: Past, Present, and Future is COPD360.

Michael W Hess1, Barry Make2.   

Abstract

The treatment and management of chronic obstructive pulmonary disease (COPD) have gone through significant changes over the past decade. This plenary session, part of the 2015 COPD9USA conference, examines how the diagnosis and management of COPD has become more individualized as new phenotypes have been identified. In addition, new diagnostic and management tools are evaluated and the importance of including the patient perspective when designing a treatment plan is discussed. Finally, the future integration of technology in research, clinical communication, and disease education is introduced, including how the COPD Foundation is encouraging and facilitating these efforts. This article serves as a CME available enduring material summary of the following COPD9USA presentations: "The Past and Present Evidence" presenter: Stephen Rennard, MD "COPD: The Way Forward" presenter: Gerard Turino, MD "E-Cigarettes-Hope, Hype or Danger?" presenter: Russell Bowler, MD, PhD "Looking Forward" presenter Prescott Woodruff, MD "The Future is Now: A Patient Perspective" presenter: Jim Nelson "COPD360 & The Patient-Powered Research Network" presenter: John Walsh.

Entities:  

Keywords:  COPD360social; PPRN; Patient-Powered Research Network; alpha- antitrypsin deficiency; chronic obstructive pulmonary disease; copd; emphysema; social media

Year:  2016        PMID: 28848869      PMCID: PMC5559129          DOI: 10.15326/jcopdf.3.1.2015.0173

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN: 2372-952X


  7 in total

1.  Electronic cigarettes for smoking cessation: a randomised controlled trial.

Authors:  Christopher Bullen; Colin Howe; Murray Laugesen; Hayden McRobbie; Varsha Parag; Jonathan Williman; Natalie Walker
Journal:  Lancet       Date:  2013-09-09       Impact factor: 79.321

2.  The natural history of chronic airflow obstruction.

Authors:  C Fletcher; R Peto
Journal:  Br Med J       Date:  1977-06-25

3.  Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats.

Authors:  G D Massaro; D Massaro
Journal:  Nat Med       Date:  1997-06       Impact factor: 53.440

Review 4.  Early chronic obstructive pulmonary disease: definition, assessment, and prevention.

Authors:  Stephen I Rennard; M Bradley Drummond
Journal:  Lancet       Date:  2015-05-02       Impact factor: 79.321

5.  Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.

Authors:  Kenneth R Chapman; Jonathan G W Burdon; Eeva Piitulainen; Robert A Sandhaus; Niels Seersholm; James M Stocks; Berend C Stoel; Liping Huang; Zhenling Yao; Jonathan M Edelman; Noel G McElvaney
Journal:  Lancet       Date:  2015-05-27       Impact factor: 79.321

6.  Levels of selected carcinogens and toxicants in vapour from electronic cigarettes.

Authors:  Maciej Lukasz Goniewicz; Jakub Knysak; Michal Gawron; Leon Kosmider; Andrzej Sobczak; Jolanta Kurek; Adam Prokopowicz; Magdalena Jablonska-Czapla; Czeslawa Rosik-Dulewska; Christopher Havel; Peyton Jacob; Neal Benowitz
Journal:  Tob Control       Date:  2013-03-06       Impact factor: 7.552

7.  EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study.

Authors:  Pasquale Caponnetto; Davide Campagna; Fabio Cibella; Jaymin B Morjaria; Massimo Caruso; Cristina Russo; Riccardo Polosa
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.